Clinical Trial Update: The Basket Study of Pyrotinib Maleate for HER2-Postive Solid Tumor [Phase 2]

View source ↗

Summary

Phase 2 basket study investigating Pyrotinib Maleate in HER2-positive solid tumors; current status and conditions listed but no results reported.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HER2 Gene Mutation
• Her-2 Gene Amplification
• Her-2 Protein Overexpression
• Solid Tumor

Drugs mentioned

• Pyrotinib maleate (pyrotinib)

Snippet

Sponsor: Tianjin Medical University Second Hospital | Conditions: Solid Tumor, HER2 Gene Mutation | Phase 2 | Status: UNKNOWN